These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 25944644)

  • 1. Mast Cell Activation Syndrome.
    Frieri M
    Clin Rev Allergy Immunol; 2018 Jun; 54(3):353-365. PubMed ID: 25944644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mast cell activation syndrome: a review.
    Frieri M; Patel R; Celestin J
    Curr Allergy Asthma Rep; 2013 Feb; 13(1):27-32. PubMed ID: 23179866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mast cell activation syndrome: improved identification by combined determinations of serum tryptase and 24-hour urine 11β-prostaglandin2α.
    Ravi A; Butterfield J; Weiler CR
    J Allergy Clin Immunol Pract; 2014; 2(6):775-8. PubMed ID: 25439370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast Cell Activation Syndrome and Mastocytosis: Initial Treatment Options and Long-Term Management.
    Castells M; Butterfield J
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1097-1106. PubMed ID: 30961835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Excretion of Mast Cell Mediator Metabolites During Mast Cell Activation Syndrome.
    Butterfield JH
    J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2542-2546. PubMed ID: 36863614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hymenoptera Allergy and Mast Cell Activation Syndromes.
    Bonadonna P; Bonifacio M; Lombardo C; Zanotti R
    Curr Allergy Asthma Rep; 2016 Jan; 16(1):5. PubMed ID: 26714690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mast cell disorders: Protean manifestations and treatment responses.
    Chen M; Kim A; Zuraw B; Doherty TA; Christiansen S
    Ann Allergy Asthma Immunol; 2018 Jul; 121(1):128-130. PubMed ID: 29604336
    [No Abstract]   [Full Text] [Related]  

  • 8. Expanding spectrum of mast cell activation disorders: monoclonal and idiopathic mast cell activation syndromes.
    Picard M; Giavina-Bianchi P; Mezzano V; Castells M
    Clin Ther; 2013 May; 35(5):548-62. PubMed ID: 23642289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why the 20% + 2 Tryptase Formula Is a Diagnostic Gold Standard for Severe Systemic Mast Cell Activation and Mast Cell Activation Syndrome.
    Valent P; Bonadonna P; Hartmann K; Broesby-Olsen S; Brockow K; Butterfield JH; Triggiani M; Lyons JJ; Oude Elberink JNG; Arock M; Metcalfe DD; Akin C
    Int Arch Allergy Immunol; 2019; 180(1):44-51. PubMed ID: 31256161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary alpha-tryptasemia in 101 patients with mast cell activation-related symptomatology including anaphylaxis.
    Giannetti MP; Weller E; Bormans C; Novak P; Hamilton MJ; Castells M
    Ann Allergy Asthma Immunol; 2021 Jun; 126(6):655-660. PubMed ID: 33465452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal.
    Valent P; Akin C; Arock M; Brockow K; Butterfield JH; Carter MC; Castells M; Escribano L; Hartmann K; Lieberman P; Nedoszytko B; Orfao A; Schwartz LB; Sotlar K; Sperr WR; Triggiani M; Valenta R; Horny HP; Metcalfe DD
    Int Arch Allergy Immunol; 2012; 157(3):215-25. PubMed ID: 22041891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survey of Mast Cell Mediator Levels from Patients Presenting with Symptoms of Mast Cell Activation.
    Butterfield JH
    Int Arch Allergy Immunol; 2020; 181(1):43-50. PubMed ID: 31722348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Challenge for Allergologist: Application of Allergy Diagnostic Methods in Mast Cell Disorders.
    Romantowski J; Górska A; Niedoszytko M; Gulen T; Gruchała-Niedoszytko M; Nedoszytko B; Lange M; Brockow K; Arock M; Akin C; Valent P
    Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33535634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mast cell activation syndromes presenting as anaphylaxis.
    Akin C
    Immunol Allergy Clin North Am; 2015 May; 35(2):277-85. PubMed ID: 25841551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low Prevalence of Idiopathic Mast Cell Activation Syndrome Among 703 Patients With Suspected Mast Cell Disorders.
    Zaghmout T; Maclachlan L; Bedi N; Gülen T
    J Allergy Clin Immunol Pract; 2024 Mar; 12(3):753-761. PubMed ID: 38056692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and laboratory parameters of mast cell activation as basis for the formulation of diagnostic criteria.
    Valent P; Horny HP; Triggiani M; Arock M
    Int Arch Allergy Immunol; 2011; 156(2):119-27. PubMed ID: 21576982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonclonal Mast Cell Activation Syndrome: A Growing Body of Evidence.
    Hamilton MJ
    Immunol Allergy Clin North Am; 2018 Aug; 38(3):469-481. PubMed ID: 30007464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversible Elevation of Tryptase Over the Individual's Baseline: Why is It the Best Biomarker for Severe Systemic Mast Cell Activation and MCAS?
    Valent P; Akin C; Arock M
    Curr Allergy Asthma Rep; 2024 Mar; 24(3):133-141. PubMed ID: 38308674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mast cell activation syndromes: definition and classification.
    Valent P
    Allergy; 2013 Apr; 68(4):417-24. PubMed ID: 23409940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mast Cell Mediators of Significance in Clinical Practice in Mastocytosis.
    Butterfield JH; Ravi A; Pongdee T
    Immunol Allergy Clin North Am; 2018 Aug; 38(3):397-410. PubMed ID: 30007459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.